[HTML][HTML] Prognostic role of immune checkpoint regulators in cholangiocarcinoma: a pilot study
L Cao, P Prithviraj, R Shrestha, R Sharma… - Journal of clinical …, 2021 - mdpi.com
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
[引用][C] Prognostic role of immune checkpoint regulators in cholangiocarcinoma: a pilot study
L Cao, P Prithviraj, R Shrestha… - Journal of Clinical …, 2021 - espace.library.uq.edu.au
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study.
L Cao, P Prithviraj, R Shrestha… - Journal of Clinical …, 2021 - search.ebscohost.com
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
[HTML][HTML] Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
L Cao, P Prithviraj, R Shrestha, R Sharma… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
[PDF][PDF] Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
L Cao, P Prithviraj, R Shrestha, R Sharma, M Anaka… - J. Clin. Med, 2021 - researchgate.net
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
L Cao, P Prithviraj, R Shrestha… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study.
L Cao, P Prithviraj, R Shrestha, R Sharma… - Journal of Clinical …, 2021 - europepmc.org
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
L Cao, P Prithviraj, R Shrestha… - Journal of Clinical …, 2021 - search.proquest.com
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study.
L Cao, P Prithviraj, R Shrestha, R Sharma… - Journal of Clinical …, 2021 - europepmc.org
Cholangiocarcinoma (CCA) is a hepatobiliary malignancy associated with steadily
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …
increasing incidence and poor prognosis. Ongoing clinical trials are assessing the …